Pharma

Century Therapeutics Stages Highest Single Day Move In 11 Months As Casdin Capital Bumps Its Stake To 5.4%

Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market

Elon Musk And Joe Rogan Criticize Psychedelics And Big Pharma's Legacy Of Profit Over Public Health

April Showers On Wall Street: Miners, Utilities Emerge As Bright Spots In Gloomy Market

Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era

Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect

Pharma's Post-Pandemic Story To Unlock A Cancer-Free Era

Beyond Tech And AI: Why The Sector Hedge Funds Prefer Is Not The One You'd Expect

2024 Marks a New Era Of Pharmaceutical Innovation

Cannabis Based Pain Relief Solution Receives European Patent Approval

Pharma Recent News

Johnson & Johnson Lost Its Court Battle But Won The Q2 Match

Last Thursday, Johnson & Johnson (NASDAQ: JNJ) has topped earnings estimates and uplifted its full-year guidance on the back of a strong medtech sales momentum.

How Technology And Economic Uncertainty Is Impacting The Life Sciences

By Lisa Om, VP of product marketing at USDM Life Sciences

5 Biotech Stocks That Could Soar Thanks To These Disruptive Healthcare Technologies

Burning Rock Narrows Losses With Drug Research As New Driver

Key Takeaways: Burning Rock’s net loss narrowed 29% to 185 million yuan in the first quarter from the same period a year earlier, helped by lower R&D and sales expenses Revenues from R&D services for drug companies more than doubled, becoming the company’s latest growth engine By Molly Wen

This 12% Dividend Yield Stock Is Set For Payout On Tuesday: What Else To Watch Out For

MediPharm Labs Debuts On US Pharmaceutical Market With Submission Of FDA DMF

CBD-based pharmaceutical company MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has completed a Drug Master File (DMF) process for CBD Active Pharmaceutical Ingredient (API) for the US Federal Drug Administration (FDA).

Pharma, Biotech Stocks Start Week With A Bang After Biogen's Alzheimer's Approval

If you’re reading this, then apparently you weren’t affected by a global internet outage that hit many news websites. The outage appeared to hurt stock futures overnight, but things recovered to flat in the hours right before the open.

After FDA Rejects Acadia Dementia Drug, Analysts Lament Lack Of Near-term Stock Drivers

ACADIA Pharmaceuticals Inc.

Morphic Holding IPO: What You Need To Know

BridgeBio Pharma IPO: What You Need To Know

Merck Signs Versum Buyout Deal; Entegris Receives Termination Payment

Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential

Analyst: Radius Health Could Advance 50% With Osteoporosis Treatment, Breast Cancer Pipeline

Barclays Injects Allergan With An Upgrade, Says Valuation Model Has Improved

A Survey Of Celgene's M&A Strategy

Argus Shares Eli Lilly's Optimism, Upgrades To Buy

10 Biotech Stocks Moving From ASH 2017

What If Trump Keeps Badmouthing Drug Pricing?

JPMorgan's Take On Big Pharma's New ASCO Abstracts

Not All Of Clinton's Policies Are Bad For Pharmaceuticals

Eli Lilly Discontinues Evacetrapib; Investors Move Bets To Alternatives

5-Star Biotech Stock Watch: Synta Pharmaceuticals

Takeover Whispers Add To Achillion Pharmaceuticals' Momentum

;